Sara Tartof to Middle Aged
This is a "connection" page, showing publications Sara Tartof has written about Middle Aged.
Connection Strength
0.746
-
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 08; 70(40):1415-1419.
Score: 0.083
-
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021 10 16; 398(10309):1407-1416.
Score: 0.083
-
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med. 2020 11 17; 173(10):773-781.
Score: 0.077
-
Antibiotic and antifungal treatment among persons with confirmed coccidioidomycosis - Southern California, 2011. Med Mycol. 2020 Apr 01; 58(3):411-413.
Score: 0.075
-
Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med. 2016 05 03; 164(9):593-9.
Score: 0.056
-
A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure. Infect Control Hosp Epidemiol. 2015 Dec; 36(12):1409-16.
Score: 0.055
-
Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. J Infect Dis. 2015 Oct 15; 212(8):1222-31.
Score: 0.053
-
Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Mayo Clin Proc. 2014 Sep; 89(9):1229-38.
Score: 0.050
-
Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011. Clin Infect Dis. 2014 Jan; 58(2):e39-43.
Score: 0.048
-
Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
Score: 0.021
-
Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score. Am J Emerg Med. 2021 Aug; 46:489-494.
Score: 0.019
-
Trends in Acute Myocardial Infarction by Race and Ethnicity. J Am Heart Assoc. 2020 03 03; 9(5):e013542.
Score: 0.019
-
Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project. Vaccine. 2019 05 31; 37(25):3296-3302.
Score: 0.018
-
Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged =60 Years. J Infect Dis. 2016 06 15; 213(12):1872-5.
Score: 0.014
-
Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease. Clin Infect Dis. 2016 Feb 15; 62(4):462-7.
Score: 0.014
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.013
-
Vaccination against zoster remains effective in older adults who later undergo chemotherapy. Clin Infect Dis. 2014 Oct; 59(7):913-9.
Score: 0.013
-
Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization. Clin Infect Dis. 2014 Jun; 58(12):1739-45.
Score: 0.012
-
Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 2013 Sep 23; 31(41):4564-8.
Score: 0.012
-
Surgery for valvular heart disease: a population-based study in a Brazilian urban center. PLoS One. 2012; 7(5):e37855.
Score: 0.011